- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00202475
Collection of Autologous Blood Products by Double Erythrocytapheresis
October 19, 2009 updated by: Sanquin Research & Blood Bank Divisions
Collection of Autologous Blood Products by Double Erythrocytapheresis - Cost Effectiveness Study
The project will determine the advantages of double erythrocytapheresis in the collection of preoperative autologous erythrocytes as compared to the standard collections of whole blood.
The study will assess the total reduction in the number of procedures required to obtain the preoperative units ordered by the surgeon.
Also, successfulness of erythrocytaphereses versus classical whole blood collection for these patients will be compared.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The project will determine the advantages of double erythrocytapheresis in the collection of preoperative autologous erythrocytes as compared to the standard collections of whole blood.
The study will assess the total reduction in the number of procedures required to obtain the preoperative units ordered by the surgeon.
Also, successfulness of erythrocytaphereses versus classical whole blood collection for these patients will be compared.
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Maastricht, Netherlands, 6229 GR
- Sanquin Blood Bank Southeast Region
-
-
Limburg
-
Maastricht, Limburg, Netherlands, 6229 GS
- Sanquin Bloodbank
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Elective surgery
Exclusion Criteria:
- Malignancies
- Severe arrhythmias
- Congestive heart failure
- Recent angina
- Epileptic seizures in the last 3 months before collection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: 2
|
collection of whole blood
Other Names:
|
Active Comparator: 1
|
machinal collection of erythrocytes
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
decline in Hemoglobine levels
Time Frame: surgery
|
surgery
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Storage parameters- ATP
Time Frame: 35 days
|
35 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Eva Rombout, MD, Sanquin Research and Blood Bank Divisions
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2003
Primary Completion (Actual)
September 1, 2006
Study Completion (Actual)
December 1, 2007
Study Registration Dates
First Submitted
September 13, 2005
First Submitted That Met QC Criteria
September 19, 2005
First Posted (Estimate)
September 20, 2005
Study Record Updates
Last Update Posted (Estimate)
October 20, 2009
Last Update Submitted That Met QC Criteria
October 19, 2009
Last Verified
October 1, 2009
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- PPO-C-02-15
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pre Operative Autologous Donation
-
Nemours Children's ClinicWithdrawnPre Operative Sedation | Mask Acceptance | Post Operative DeleriumUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedPre-operative Haemorrhagic RiskFrance
-
Milton S. Hershey Medical CenterRecruiting
-
Children's Mercy Hospital Kansas CityUniversity of North CarolinaWithdrawn
-
University Health Network, TorontoUnknownLow-value Pre-operative InvestigationsCanada
-
Unity Health TorontoUnknownSurgical Videos | Pre-operative TrainingCanada
-
Technical University of MunichHealth Information Management, BelgiumCompletedAdults | Non-cardiac Surgery | Pre-operative AssessmentGermany
-
University of NottinghamCompletedElderly | Prehabilitation | Interval Training | Pre Operative ExerciseUnited Kingdom
-
IWK Health CentreCompletedPre-operative AnxietyCanada
-
Rennes University HospitalCompletedPregnancy | Oocyte DonationFrance